| | | |   | | | | By Ed Silverman Adobe Drugmakers and PBMs inflated the price of insulin to line their own pockets, claimed Arkansas Attorney General Leslie Rutledge. Read More | | By Ed Silverman Adobe The NIH has agreed to license nearly a dozen technologies to a WHO program created to boost access to Covid-19 medical products. Read More | | By Adam Feuerstein Elizabeth D. Herman for STAT The study results are preliminary but establish Caribou’s presence among a group of drugmakers leveraging genome-editing technologies. Read More | | Sponsor content by Novartis The latest in cancer care: three scientific advances to watch For most of human history, our options for treating cancer were limited. Things changed with the emergence of new categories of medicines, particularly targeted therapies and immunotherapies, which now serve as pillars of cancer care. Cancer, however, is far from solved, and there remains an urgent need not just for new treatments, but for new pillars. That's why we're pursuing technologies we think have this potential. Here are three we're especially excited about. | | By Damian Garde and Meg Tirrell and Adam Feuerstein This episode, we examine the arrest of Seagen CEO Clay Siegall and the unanswered questions about the company's response. Read More | |
No comments